SyntheticMR invests in the sales organization globally
SyntheticMR strengthens the sales organization for continued growth through increased geographical presence and market penetration. The investment is initiated as short term growth is not expected to reach the level of the company ambition.
The company recently established a subsidiary in the US and the head of the US market started the employment on August 1 this year. Within the scope of the investment in the US, the company has now decided to invest in additional personnel sales resources, planned for before the end of the year. At the same time, the company has also decided to increase its presence in Asia and is now represented with staff in both India and Japan.
“SyntheticMR is a growth company with the potential to establish the products in the global market. The conditions for sales growth in the long-term are strengthened through deeper cooperation with our partners and increased presence in each market. We make these investments to together with our partners work with the end customers and increase the company visibility and strengthen the global position of SyntheticMR, ”says Ulrik Harrysson, CEO, SyntheticMR.
For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 or Fredrik Jeppsson, CFO and Head of Investor Realtions, SyntheticMR AB, +46 72 303 13 39
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB product SyMRI® delivers multiple contrast images and quantitative data from a single 6-minute scan – to improve patient throughput and objective decision support for clinicians. SyMRI is CE-marked and FDA 510(k) cleared. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the Spotlight Stock Market in Stockholm, Sweden. For additional information, please visit www.syntheticmr.com.
This information is information that SyntheticMR AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on September 4th, 2019